In subgroup analysis, the combination of anti-HCV and HCV-Ag showed similar sensitivity and specificity for diagnosing HCV infection in patients, with 100% sensitivity and 100% specificity in mono-infection and 99.3% sensitivity and 100% specificity in coinfection (Supplementary Table S1). The gene discussed is RENBP; the disease is infection.